We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





US COVID-19 Testing Supply Data Reveal One Million Tests Being Shipped Per Day

By LabMedica International staff writers
Posted on 31 Jul 2020
Data released by a US national COVID-19 diagnostic supply registry shows that over one million SARS-CoV-2 tests are being shipped every day.

The national registry has been created by the Advanced Medical Technology Association (AdvaMed Washington, D.C., USA) in partnership with 13 commercial diagnostics manufacturers: Abbott, BD, bioMérieux, Bio-Rad, Beckman Coulter, Cepheid, Hologic, Ortho Clinical Diagnostics, QIAGEN, Roche Diagnostics, Sekisui Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. More...
The tests offered by these 13 leading diagnostic manufacturers together comprise ~95% of the COVID-19 tests on the market in the US. AdvaMed is also working closely with the White House, HHS, FDA, FEMA and other key government agencies to ensure the continued supply of diagnostics tests, as well as other vital medical equipment such as PPE and ventilators, in the fight against the COVID-19 pandemic.

According to key data of the US COVID testing supply released by AdvaMed, over100 commercial tests for COVID-19 have secured authorization by the US FDA. Across leading COVID diagnostic manufacturers, roughly 80 million molecular COVID-19 tests have been manufactured and shipped since March. Manufacturers have increased molecular test production from about 450,0001 shipments per day at the start of May to over 870,0001 shipments per day by July 18. The past week’s shipping patterns show an all-time weekly high of one million tests shipped per day.

As per public sources, daily molecular test runs continue to grow rapidly as well, increasing by ~30% to date in July vs. June’s average, reaching an all-time peak of about 775,000 tests per day by mid-July. High-quality serology testing, authorized by the FDA, is now available at scale with industry capacity to manufacture 100 million tests per month.

Related Links:
Advanced Medical Technology Association (AdvaMed)


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.